Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose

Status unconfirmed

Conditions studied: Drug Overdose, Opioid-Related Disorders

In brief

RTM Vital Signs, LLC is developing a miniature wearable tracheal sound sensor that communicates with a cell phone containing a machine-learning diagnostic algorithm designed to detect and predict the onset of mild, moderate, and severe hypoventilation (respiratory depression) due to an opioid overdose. The purpose of this clinical trial is to develop/validate diagnostic algorithms capable of detecting/predicting the onset of hypoventilation induced by a controlled intravenous infusion of fentanyl. The wearable sensor and algorithms will provide a series of alerts and alarms to the person, caregiver, and/or emergency personnel.

Key facts

Study ID
NCT03845699
Run by
RTM Vital Signs, LLC
People needed
20
Starts
2019-05-15
Expected to finish
2020-05-14
Last updated by the study team
2019-05-09

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.